Anixa Biosciences, Inc. reported earnings results for the full year ended October 31, 2022. For the full year, the company reported net loss was USD 13.6 million compared to USD 12.95 million a year ago. Basic loss per share from continuing operations was USD 0.45 compared to USD 0.45 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.84 USD | -0.35% | -4.38% | -26.80% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.80% | 90.91M | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- ANIX Stock
- News Anixa Biosciences, Inc.
- Anixa Biosciences, Inc. Reports Earnings Results for the Full Year Ended October 31, 2022